Silver Book Fact

The cost-effectiveness of detection and treatment of eye disease in diabetics is $3,190 per quality adjusted life year (QALY).

Javitt, Jonathan C., and Lloyd Paul Aiello. Cost-Effectiveness of Detecting and Treating Diabetic Retinopathy. Annals of Internal Medicine. 1996; 124(1): 164-9. http://www.annals.org/cgi/content/abstract/124/1_Part_2/164

Reference

Title
Cost-Effectiveness of Detecting and Treating Diabetic Retinopathy
Publication
Annals of Internal Medicine
Publication Date
1996
Authors
Javitt, Jonathan C., and Lloyd Paul Aiello
Volume & Issue
Volume 124, Issue 1
Pages
164-9
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • The NEI-sponsored Ocular Hypertensive Treatment Study (OHTS) found that lowering intraocular pressure (IOP) by at least 20% produced a 50% protective benefit for individuals who had an elevated IOP but…  
  • Of the 8 Million older Americans at high risk of developing advanced age-related macular degeneration (AMD), 1.3 million will develop advanced AMD within 5 years.  However the NEI-sponsored Age-Related Eye…  
  • Tele-ophthalmology
    Adequately trained general practitioners can screen for DR with 90% sensitivity using tele-ophthalmology.  
  • Detection and treatment of proliferative diabetic eye disease and clincally significant macular edema with laser therapy can reduce severe vision loss progression by 50% to 60%  
  • Multifoca electroretinogram (mFERG) measures show abnormal function of the retina early in–and even prior to–diabetic retinopathy onset and could enhance monitoring of the early stages of disease progression in individuals.